The conversation delves into the complexities of dietary supplement regulation, highlighting that while the FDA does not pre-approve these products like drugs, it still oversees their manufacturing processes. Richard explains that consumer demand for less oversight has influenced the current regulatory landscape, leading to confusion about the safety and efficacy of supplements. The discussion also touches on the distinct regulatory environments for food, drugs, and other health-related products, emphasizing the challenges consumers face in navigating these differences.
